Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas.

Wu CC, Jain R, Neto L, Patel S, Poisson LM, Serrano J, Ng V, Patel SH, Placantonakis DG, Zagzag D, Golfinos J, Chi AS, Snuderl M.

Neuroradiology. 2019 Sep;61(9):1023-1031. doi: 10.1007/s00234-019-02219-8. Epub 2019 May 27.

PMID:
31134296
2.

Clinical and research applications of a brain tumor tissue bank in the age of precision medicine.

Snyder J, Poisson LM, Noushmehr H, Castro AV, deCarvalho AC, Robin A, Mukherjee A, Lee I, Walbert T.

Per Med. 2019 Mar;16(2):145-156. doi: 10.2217/pme-2018-0102. Epub 2019 Feb 28.

3.

Imaging and diagnostic advances for intracranial meningiomas.

Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougère C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i44-i61. doi: 10.1093/neuonc/noy143.

PMID:
30649491
4.

Molecular and translational advances in meningiomas.

Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H, Perry A, Sahm F, Sloan A, Von Deimling A, Wen PY, Aldape K, Zadeh G; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i4-i17. doi: 10.1093/neuonc/noy178.

PMID:
30649490
5.

Advances in multidisciplinary therapy for meningiomas.

Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i18-i31. doi: 10.1093/neuonc/noy136.

PMID:
30649489
6.

Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life.

Nassiri F, Price B, Shehab A, Au K, Cusimano MD, Jenkinson MD, Jungk C, Mansouri A, Santarius T, Suppiah S, Teng KX, Toor GS, Zadeh G, Walbert T, Drummond KJ; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i32-i43. doi: 10.1093/neuonc/noy152.

PMID:
30649488
7.

Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.

Halani SH, Yousefi S, Velazquez Vega J, Rossi MR, Zhao Z, Amrollahi F, Holder CA, Baxter-Stoltzfus A, Eschbacher J, Griffith B, Olson JJ, Jiang T, Yates JR, Eberhart CG, Poisson LM, Cooper LAD, Brat DJ.

NPJ Precis Oncol. 2018 Nov 6;2:24. doi: 10.1038/s41698-018-0067-9. eCollection 2018.

8.

Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.

Singh J, Cerghet M, Poisson LM, Datta I, Labuzek K, Suhail H, Rattan R, Giri S.

J Neuroimmune Pharmacol. 2019 Jun;14(2):241-250. doi: 10.1007/s11481-018-9815-4. Epub 2018 Oct 12.

PMID:
30315511
9.

Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.

Wu CC, Jain R, Radmanesh A, Poisson LM, Guo WY, Zagzag D, Snuderl M, Placantonakis DG, Golfinos J, Chi AS.

AJNR Am J Neuroradiol. 2018 Oct;39(10):1814-1820. doi: 10.3174/ajnr.A5794. Epub 2018 Sep 6.

PMID:
30190259
10.

Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas.

Chang P, Grinband J, Weinberg BD, Bardis M, Khy M, Cadena G, Su MY, Cha S, Filippi CG, Bota D, Baldi P, Poisson LM, Jain R, Chow D.

AJNR Am J Neuroradiol. 2018 Jul;39(7):1201-1207. doi: 10.3174/ajnr.A5667. Epub 2018 May 10.

11.

CSF Pressure Change in Relation to Opening Pressure and CSF Volume Removed.

Griffith B, Capobres T, Patel SC, Marin H, Katramados A, Poisson LM.

AJNR Am J Neuroradiol. 2018 Jun;39(6):1185-1190. doi: 10.3174/ajnr.A5642. Epub 2018 May 3.

12.

Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma.

deCarvalho AC, Kim H, Poisson LM, Winn ME, Mueller C, Cherba D, Koeman J, Seth S, Protopopov A, Felicella M, Zheng S, Multani A, Jiang Y, Zhang J, Nam DH, Petricoin EF, Chin L, Mikkelsen T, Verhaak RGW.

Nat Genet. 2018 May;50(5):708-717. doi: 10.1038/s41588-018-0105-0. Epub 2018 Apr 23.

13.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.

Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V; Cancer Genome Atlas Research Network, Hu H.

Cell. 2018 Apr 5;173(2):400-416.e11. doi: 10.1016/j.cell.2018.02.052.

14.
15.

T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project.

Patel SH, Poisson LM, Brat DJ, Zhou Y, Cooper L, Snuderl M, Thomas C, Franceschi AM, Griffith B, Flanders AE, Golfinos JG, Chi AS, Jain R.

Clin Cancer Res. 2017 Oct 15;23(20):6078-6085. doi: 10.1158/1078-0432.CCR-17-0560. Epub 2017 Jul 27.

16.

The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells.

Brodie S, Lee HK, Jiang W, Cazacu S, Xiang C, Poisson LM, Datta I, Kalkanis S, Ginsberg D, Brodie C.

Oncotarget. 2017 May 9;8(19):31785-31801. doi: 10.18632/oncotarget.15991.

17.

Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis.

Poisson LM, Suhail H, Singh J, Datta I, Denic A, Labuzek K, Hoda MN, Shankar A, Kumar A, Cerghet M, Elias S, Mohney RP, Rodriguez M, Rattan R, Mangalam AK, Giri S.

J Biol Chem. 2015 Dec 25;290(52):30697-712. doi: 10.1074/jbc.M115.679068. Epub 2015 Nov 6.

18.

Identification of regions of normal grey matter and white matter from pathologic glioblastoma and necrosis in frozen sections using Raman imaging.

Kast R, Auner G, Yurgelevic S, Broadbent B, Raghunathan A, Poisson LM, Mikkelsen T, Rosenblum ML, Kalkanis SN.

J Neurooncol. 2015 Nov;125(2):287-95. doi: 10.1007/s11060-015-1929-4. Epub 2015 Sep 10.

PMID:
26359131
19.

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Sabedot TS, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T Jr, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG Jr, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, Finocchiaro G, Friedman W, Fulop J, Gardner J, Hermes B, Herold-Mende C, Jungk C, Kendler A, Lehman NL, Lipp E, Liu O, Mandt R, McGraw M, Mclendon R, McPherson C, Neder L, Nguyen P, Noss A, Nunziata R, Ostrom QT, Palmer C, Perin A, Pollo B, Potapov A, Potapova O, Rathmell WK, Rotin D, Scarpace L, Schilero C, Senecal K, Shimmel K, Shurkhay V, Sifri S, Singh R, Sloan AE, Smolenski K, Staugaitis SM, Steele R, Thorne L, Tirapelli DP, Unterberg A, Vallurupalli M, Wang Y, Warnick R, Williams F, Wolinsky Y, Bell S, Rosenberg M, Stewart C, Huang F, Grimsby JL, Radenbaugh AJ, Zhang J.

N Engl J Med. 2015 Jun 25;372(26):2481-98. doi: 10.1056/NEJMoa1402121. Epub 2015 Jun 10.

20.

A metabolomic approach to identifying platinum resistance in ovarian cancer.

Poisson LM, Munkarah A, Madi H, Datta I, Hensley-Alford S, Tebbe C, Buekers T, Giri S, Rattan R.

J Ovarian Res. 2015 Mar 26;8:13. doi: 10.1186/s13048-015-0140-8.

21.

RasGRP3 regulates the migration of glioma cells via interaction with Arp3.

Lee HK, Finniss S, Cazacu S, Xiang C, Poisson LM, Blumberg PM, Brodie C.

Oncotarget. 2015 Jan 30;6(3):1850-64.

22.

Raman molecular imaging of brain frozen tissue sections.

Kast RE, Auner GW, Rosenblum ML, Mikkelsen T, Yurgelevic SM, Raghunathan A, Poisson LM, Kalkanis SN.

J Neurooncol. 2014 Oct;120(1):55-62. doi: 10.1007/s11060-014-1536-9. Epub 2014 Jul 20.

PMID:
25038847
23.

Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival.

Thomas SL, Schultz CR, Mouzon E, Golembieski WA, El Naili R, Radakrishnan A, Lemke N, Poisson LM, Gutiérrez JA, Cottingham S, Rempel SA.

Brain Pathol. 2015 Jul;25(4):391-400. doi: 10.1111/bpa.12161. Epub 2015 Apr 20.

24.

Key determinants of short-term and long-term glioblastoma survival: a 14-year retrospective study of patients from the Hermelin Brain Tumor Center at Henry Ford Hospital.

Mazaris P, Hong X, Altshuler D, Schultz L, Poisson LM, Jain R, Mikkelsen T, Rosenblum M, Kalkanis S.

Clin Neurol Neurosurg. 2014 May;120:103-12. doi: 10.1016/j.clineuro.2014.03.001. Epub 2014 Mar 12.

PMID:
24731587
25.

Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.

Berezovsky AD, Poisson LM, Cherba D, Webb CP, Transou AD, Lemke NW, Hong X, Hasselbach LA, Irtenkauf SM, Mikkelsen T, deCarvalho AC.

Neoplasia. 2014 Mar;16(3):193-206, 206.e19-25. doi: 10.1016/j.neo.2014.03.006. Epub 2014 Apr 13.

26.

Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.

Jain R, Poisson LM, Gutman D, Scarpace L, Hwang SN, Holder CA, Wintermark M, Rao A, Colen RR, Kirby J, Freymann J, Jaffe CC, Mikkelsen T, Flanders A.

Radiology. 2014 Aug;272(2):484-93. doi: 10.1148/radiol.14131691. Epub 2014 Mar 19.

27.

Raman spectroscopy to distinguish grey matter, necrosis, and glioblastoma multiforme in frozen tissue sections.

Kalkanis SN, Kast RE, Rosenblum ML, Mikkelsen T, Yurgelevic SM, Nelson KM, Raghunathan A, Poisson LM, Auner GW.

J Neurooncol. 2014 Feb;116(3):477-85. doi: 10.1007/s11060-013-1326-9. Epub 2014 Jan 4.

PMID:
24390405
28.

Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.

Mangalam A, Poisson L, Nemutlu E, Datta I, Denic A, Dzeja P, Rodriguez M, Rattan R, Giri S.

J Clin Cell Immunol. 2013 Jun 30;4. doi: 10.4172/2155-9899.1000150.

29.

The somatic genomic landscape of glioblastoma.

Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O'Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L; TCGA Research Network.

Cell. 2013 Oct 10;155(2):462-77. doi: 10.1016/j.cell.2013.09.034. Erratum in: Cell. 2014 Apr 24;157(3):753.

30.

Heterogeneity of bone mineral density and fatigue failure of human vertebrae.

Yeni YN, Poisson LM, Flynn MJ.

J Biomech. 2013 Apr 26;46(7):1396-9. doi: 10.1016/j.jbiomech.2013.02.015. Epub 2013 Mar 26.

31.

MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.

Lee HK, Bier A, Cazacu S, Finniss S, Xiang C, Twito H, Poisson LM, Mikkelsen T, Slavin S, Jacoby E, Yalon M, Toren A, Rempel SA, Brodie C.

PLoS One. 2013;8(2):e54652. doi: 10.1371/journal.pone.0054652. Epub 2013 Feb 4.

32.

PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma.

Alam R, Schultz CR, Golembieski WA, Poisson LM, Rempel SA.

Neuro Oncol. 2013 Apr;15(4):451-61. doi: 10.1093/neuonc/nos326. Epub 2013 Feb 3.

33.

Skin-of-color epidemiology: a report of the most common skin conditions by race.

Henderson MD, Abboud J, Cogan CM, Poisson LM, Eide MJ, Shwayder TA, Lim HW.

Pediatr Dermatol. 2012 Sep-Oct;29(5):584-9. doi: 10.1111/j.1525-1470.2012.01775.x. Epub 2012 May 29.

PMID:
22639933
34.

Pathway-directed weighted testing procedures for the integrative analysis of gene expression and metabolomic data.

Poisson LM, Sreekumar A, Chinnaiyan AM, Ghosh D.

Genomics. 2012 May;99(5):265-74. doi: 10.1016/j.ygeno.2012.03.004. Epub 2012 Apr 2.

35.

Identification of mouse serum miRNA endogenous references by global gene expression profiles.

Mi QS, Weiland M, Qi RQ, Gao XH, Poisson LM, Zhou L.

PLoS One. 2012;7(2):e31278. doi: 10.1371/journal.pone.0031278. Epub 2012 Feb 10.

36.

Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.

Lehman NL, O'Donnell JP, Whiteley LJ, Stapp RT, Lehman TD, Roszka KM, Schultz LR, Williams CJ, Mikkelsen T, Brown SL, Ecsedy JA, Poisson LM.

Cell Cycle. 2012 Feb 1;11(3):489-502. doi: 10.4161/cc.11.3.18996. Epub 2012 Feb 1.

37.

Integrative set enrichment testing for multiple omics platforms.

Poisson LM, Taylor JM, Ghosh D.

BMC Bioinformatics. 2011 Nov 25;12:459. doi: 10.1186/1471-2105-12-459.

38.

Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.

Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghoshd D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM.

Eur Urol. 2010 Sep;58(3):e29-30; author reply e31-2. doi: 10.1016/j.eururo.2010.05.003. Epub 2010 May 18. No abstract available.

39.

Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

Khan AP, Poisson LM, Bhat VB, Fermin D, Zhao R, Kalyana-Sundaram S, Michailidis G, Nesvizhskii AI, Omenn GS, Chinnaiyan AM, Sreekumar A.

Mol Cell Proteomics. 2010 Feb;9(2):298-312. doi: 10.1074/mcp.M900159-MCP200. Epub 2009 Nov 9.

40.

The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray.

Patwa TH, Li C, Poisson LM, Kim HY, Pal M, Ghosh D, Simeone DM, Lubman DM.

Electrophoresis. 2009 Jun;30(12):2215-26. doi: 10.1002/elps.200800857.

41.

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM.

Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. Erratum in: Nature. 2013 Jul 25;499(7459):504.

42.

"Omics" data and levels of evidence for biomarker discovery.

Ghosh D, Poisson LM.

Genomics. 2009 Jan;93(1):13-6. doi: 10.1016/j.ygeno.2008.07.006. Epub 2008 Sep 14. Review.

44.

Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications?

Cooper GS, Johnson CC, Lamerato L, Poisson LM, Schultz L, Simpkins J, Wells K, Yood MU, Chase G, Nathanson SD, Lafata JE.

Med Care. 2006 Jun;44(6):590-4.

PMID:
16708008
45.

Estimating post-traumatic stress disorder in the community: lifetime perspective and the impact of typical traumatic events.

Breslau N, Peterson EL, Poisson LM, Schultz LR, Lucia VC.

Psychol Med. 2004 Jul;34(5):889-98.

PMID:
15500309
46.

Sarcoidosis and granuloma genes: a family-based study in African-Americans.

Rybicki BA, Maliarik MJ, Poisson LM, Iannuzzi MC.

Eur Respir J. 2004 Aug;24(2):251-7.

47.

Susceptibility scoring in family-based association testing.

Poisson LM, Rybicki BA, Coon SW, Barnholtz-Sloan JS, Chase GA.

BMC Genet. 2003 Dec 31;4 Suppl 1:S49.

48.

Analysis of gene x environment interactions in sibships using mixed models.

Barnholtz-Sloan JS, Poisson LM, Coon SW, Chase GA, Rybicki BA.

BMC Genet. 2003 Dec 31;4 Suppl 1:S18.

49.

Effects of covariates: a summary of Group 5 contributions.

Hauser ER, Hsu FC, Daley D, Olson JM, Rampersaud E, Lin JP, Paterson AD, Poisson LM, Chase GA, Dahmen G, Ziegler A.

Genet Epidemiol. 2003;25 Suppl 1:S43-9.

PMID:
14635168
50.

Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans.

Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA.

Am J Respir Crit Care Med. 2003 May 1;167(9):1225-31. Epub 2003 Feb 13.

PMID:
12615619

Supplemental Content

Loading ...
Support Center